Patent US4767788A successfully refreshed from Google Patents.
US4767788A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Glutaric acid virucidal processes and compositions
Assignee: STWB Inc
•
Filing: 1982-03-29
•
Granted: 1988-08-30
•
Expires: 2002-03-29
Abstract
Abstract The process of, and compositions, articles and packages for, inactivating or destroying viruses with glutaric acid are disclosed.
Inventors
- 👤 Guy D. Diana
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 10:21
CPC Classifications
C; C12; C12N; C12N7/00; A; A01; A01N; A01N37/00; A01N37/02; A01N37/04; C12N2770/00; C12N2770/00011; C12N2770/32011; C12N2770/32061; C12N2770/32063
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
28 words
The process of inactivating or destroying a susceptible virus which comprises contacting the virus or a locus of the virus with a virucidally effective amount of glutaric acid.
Claim 2
Dependent Claim
28 words
The process of inactivating or destroying a susceptible virus which comprises contacting the virus or a locus of the virus with a virucidally effective amount of glutaric acid.
Claim 3
Dependent Claim
27 words
The process according to claim 1 wherein the virus is a rhinovirus, a herpes simplex virus, an influenza virus, a parainfluenza virus or a respiratory syncytial virus.
Claim 4
Dependent Claim
31 words
The process according to claim 1 wherein the glutaric acid is in the form of a composition consisting essentially of a virucidally effective concentration of glutaric acid and a pharmaceutical vehicle.
Claim 5
Dependent Claim
31 words
The process of reducing rhinovirus titer in the nasal mucosa of a mammal infected by a rhinovirus which comprises administering intranasally to the mammal a rhinovirucidally effective amount of glutaric acid.
Claim 6
Dependent Claim
31 words
The process of reducing rhinovirus titer in the nasal mucosa of a mammal infected by a rhinovirus which comprises administering intranasally to the mammal a rhinovirucidally effective amount of glutaric acid.
Claim 7
Dependent Claim
31 words
The process according to claim 4 wherein the glutaric acid is in the form of a composition consisting essentially of a virucidally effective concentration of glutaric acid and a pharmaceutical vehicle.
Claim 8
Dependent Claim
28 words
A composition for inactivating or destroying a susceptible virus on mammal skin which consists essentially of a virucidally effective concentration of glutaric acid and an aqueous surfactant-emollient mixture.
Claim 9
Dependent Claim
28 words
A composition for inactivating or destroying a susceptible virus on mammal skin which consists essentially of a virucidally effective concentration of glutaric acid and an aqueous surfactant-emollient mixture.
Claim 10
Dependent Claim
15 words
A composition according to claim 6 wherein the aqueous surfactant-emollient mixture is an aerosol mixture.
Claim 11
Dependent Claim
15 words
A composition according to claim 6 prepared for being dispensed in pre-moistened pads or tissues.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-08-30 | 1992-02-29 | 1992-08-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-08-30 | 1996-02-29 | 1996-08-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-08-30 | 2000-02-29 | 2000-08-30 | $7700.00 | Window Closed / Lapsed |